Aravive Inc
Change company Symbol lookup
Select an option...
ARAV Aravive Inc
CBU Community Bank System Inc
FPA First Trust Asia Pacific Ex-Japan AlphaDEX® Fund
GER Goldman Sachs MLP and Energy Renaissance Fund
FNX First Trust Mid Cap Core AlphaDEX® Fund
FNK First Trust Mid Cap Value AlphaDEX® Fund
FMK First Trust Mega Cap AlphaDEX® Fund
FLN First Trust Latin America AlphaDEX® Fund
FKU First Trust United Kingdom AlphaDEX® Fund
FKO First Trust South Korea AlphaDEX® Fund
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Aravive, Inc., formerly Versartis, Inc., is a clinical-stage biotechnology company. The Company is focused on developing therapies that target survival pathways for both solid tumors, as well as hematologic malignancies. Its primary therapeutic focus is the growth arrest-specific 6 (GAS6) - AXL receptor tyrosine kinase (AXL) pathway, where AXL receptor signaling promotes metastasis, cancer cell survival, resistance to treatments and immune suppression. The Company’s lead candidate, Aravive-S6 (AVB-S6)-500, is a GAS6 binding protein and AXL decoy receptor. It is a Fc -chimeric fusion protein designed to block the activation of the Growth arrest-specific 6 (GAS6)-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL. Its AXL decoy receptor is a protein based on the extracellular portion of AXL that binds its ligand GAS6, sequesters it from the native receptor and prevents AXLmediated signaling.

Closing Price
$8.26
Day's Change
0.4248 (5.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.28
Day's Low
7.82
Volume
(Above Average)
Volume:
43,249

10-day average volume:
39,089
43,249

UPDATE: What's more volatile than bitcoin? You may be surprised

9:08 am ET October 25, 2018 (MarketWatch)
Print

By Aaron Hankin

Bitcoin's 20-day historical volatility is nearly as low as Apple

Day traders looking to make a quick buck buying and selling bitcoin might be better off switching lanes as volatility in the world's largest digital currency continues to decline.

In fact, volatility in the No.1 virtual currency is now below some of the biggest and most popular stocks on Wall Street.

According to data from Cboe Global Markets, the 20-day historical volatility, or HV, of bitcoin has fallen to 31.5%, below that of online retail giant Amazon.com (35%),(AMZN) tech-darling Netflix (52%)(NFLX) and Nvidia Corp, (40%)(NVDA) the chip producer that sells GPU cards to bitcoin miners. Furthermore, it's creeping towards that of tech-behemoth Apple Inc. (29.3%)(AAPL)--one of the most popular stocks on Wall Street.

"A one standard deviation move for bitcoin at present is about $475. That works out to +/- 7.3% (475/6500). Compare that to earlier this year (mid-January) when bitcoin was around $11,000. Back then the standard deviation measured $4640 or +/- 42%," wrote Kevin Davitt, a senior instructor at The Options Institute at Cboe.

When the price of bitcoin was tumbling from its record-high near $20,000 earlier in the year, its 20-day HV, reached 140%. But that pales in comparison to that of cannabis producer Tilray Inc.. The Vancouver-based company became the bellwether for volatility when it went public in July at $17 a share before trading to $300. Tilray's 20-day HV is currently 219%, according to data from Cboe.

Read:Tilray stock halted several times amid roller coaster final hour of trading (http://www.marketwatch.com/story/tilray-trading-paused-twice-due-to-stock-volatility-2018-09-19)

(http://www.marketwatch.com/story/tilray-trading-paused-twice-due-to-stock-volatility-2018-09-19)Yet while day traders are yearning for bitcoin volatility to pick up, evangelists--those who believe decentralized technology to be the new financial frontier--are lapping up the news as detractors regularly cite excessive volatility as a significant hurdle for adoption.

"Perhaps we are witnessing the maturation of a market. It's far too early to declare this the "new normal" but the persistent range over the last few weeks may be hinting at a structural shift. Time will tell," wrote Davitt.

Read:Here's what cooled the bitcoin trading frenzy (http://www.marketwatch.com/story/heres-what-cooled-the-bitcoin-trading-frenzy-2018-10-02)

-Aaron Hankin; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

October 25, 2018 09:08 ET (13:08 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.